DK0901463T3 - Glycerolipidforbindelser, som anvendes til overførsel af aktivstof til en målcelle - Google Patents
Glycerolipidforbindelser, som anvendes til overførsel af aktivstof til en målcelleInfo
- Publication number
- DK0901463T3 DK0901463T3 DK98908156T DK98908156T DK0901463T3 DK 0901463 T3 DK0901463 T3 DK 0901463T3 DK 98908156 T DK98908156 T DK 98908156T DK 98908156 T DK98908156 T DK 98908156T DK 0901463 T3 DK0901463 T3 DK 0901463T3
- Authority
- DK
- Denmark
- Prior art keywords
- active substance
- target cell
- compounds used
- alkyl
- transfer active
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 4
- -1 Glycerolipid compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000001890 transfection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Otolaryngology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9701475A FR2759367A1 (fr) | 1997-02-10 | 1997-02-10 | Glycerolipides cationiques et complexes de glycerolipides cationiques et de substances actives, notamment pour la transfection de cellules |
| FR9715805A FR2759382A1 (fr) | 1997-02-10 | 1997-12-12 | Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique |
| PCT/FR1998/000250 WO1998034910A1 (fr) | 1997-02-10 | 1998-02-10 | Composes glycerolipidiques utiles pour le transfert d'une substance active dans une cellule cible |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0901463T3 true DK0901463T3 (da) | 2000-10-23 |
Family
ID=26233309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98908156T DK0901463T3 (da) | 1997-02-10 | 1998-02-10 | Glycerolipidforbindelser, som anvendes til overførsel af aktivstof til en målcelle |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6218370B1 (da) |
| EP (1) | EP0901463B1 (da) |
| JP (1) | JP2000510869A (da) |
| AT (1) | ATE193886T1 (da) |
| AU (1) | AU727204B2 (da) |
| CA (1) | CA2251999A1 (da) |
| DE (1) | DE69800178T2 (da) |
| DK (1) | DK0901463T3 (da) |
| ES (1) | ES2149043T3 (da) |
| FR (1) | FR2759382A1 (da) |
| GR (1) | GR3034317T3 (da) |
| PT (1) | PT901463E (da) |
| WO (1) | WO1998034910A1 (da) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2759382A1 (fr) * | 1997-02-10 | 1998-08-14 | Transgene Sa | Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique |
| US6849272B1 (en) * | 1999-04-21 | 2005-02-01 | Massachusetts Institute Of Technology | Endosomolytic agents and cell delivery systems |
| EP1052287A3 (en) * | 1999-05-10 | 2003-07-09 | Transgene S.A. | Complex for transferring an anionic substance of interest into a cell |
| EP1052288A1 (en) * | 1999-05-10 | 2000-11-15 | Transgene S.A. | Complex for transferring an anionic substance of interest into a cell |
| WO2001042200A1 (en) * | 1999-12-10 | 2001-06-14 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| EP1261620A2 (en) * | 2000-02-07 | 2002-12-04 | Roche Diagnostics Corporation | Cationic amphiphiles for use in nucleic acid transfection |
| GB0106041D0 (en) * | 2001-03-12 | 2001-05-02 | Cancer Res Ventures Ltd | Lipids and liposomes |
| US20070111201A1 (en) * | 2001-04-30 | 2007-05-17 | Benjamin Doranz | Reverse transfection of cell arrays for structural and functional analyses of proteins |
| CA2447548A1 (en) * | 2001-05-15 | 2002-11-21 | Transgene S.A. | Complexes for transferring substances of interest into a cell |
| CA2486967A1 (en) * | 2002-05-24 | 2003-12-04 | Neopharm, Inc. | Cardiolipin compositions their methods of preparation and use |
| EA200401565A1 (ru) * | 2002-05-24 | 2005-04-28 | Неофарм, Инк. | Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты) |
| US20050277611A1 (en) * | 2002-10-16 | 2005-12-15 | Neopharm, Inc. | Cationic cardiolipin analoges and its use thereof |
| DK1649023T3 (da) | 2003-07-21 | 2008-10-06 | Transgene Sa | Polypeptid med forbedret cytosindeaminaseaktivitet |
| US8062891B2 (en) | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
| AU2004297533B2 (en) | 2003-10-24 | 2010-04-29 | Gencia Corporation | Methods and compositions for delivering polynucleotides |
| US8507277B2 (en) | 2003-10-24 | 2013-08-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides |
| WO2005039558A1 (en) * | 2003-10-24 | 2005-05-06 | Transgene S.A. | Targeted delivery of therapeutically active compounds |
| US20090123468A1 (en) | 2003-10-24 | 2009-05-14 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
| US8133733B2 (en) | 2003-10-24 | 2012-03-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to target tissues |
| EP1743440B1 (en) * | 2004-08-05 | 2009-10-07 | LG Electronics, Inc. | Interrupting use of frequency layer convergence scheme |
| GB0425556D0 (en) * | 2004-11-19 | 2004-12-22 | Glaxo Group Ltd | Novel compounds |
| JP5172188B2 (ja) * | 2007-03-28 | 2013-03-27 | 富士フイルム株式会社 | フッ素置換アルキル基を有するグリセリド化合物 |
| US8357531B2 (en) | 2007-07-03 | 2013-01-22 | Transgene S.A. | Immortalized avian cell lines |
| FR2921369B1 (fr) * | 2007-09-25 | 2014-07-11 | Pf Medicament | Nouveau procede de preparation de derives (poly) aminoalkylaminoacetamide d'epipodophyllotoxine,utiles pour leurs applications en therapeutique comme agent anticancereux. |
| US8470977B2 (en) | 2008-03-14 | 2013-06-25 | Transgene S.A. | Antibody against the CSF-1R |
| CA2744294A1 (en) | 2009-01-13 | 2010-07-22 | Transgene Sa | Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation |
| CN110418650A (zh) | 2016-11-16 | 2019-11-05 | 免疫治疗有限公司 | 用于治疗过敏的核酸 |
| EP3612556B8 (en) | 2017-04-22 | 2024-11-20 | Immunomic Therapeutics, Inc. | Improved lamp constructs |
| WO2018204534A1 (en) | 2017-05-02 | 2018-11-08 | Immunomic Therapeutics, Inc. | Lamp (lysosomal associated membrane protein) constructs comprising cancer antigens |
| JP2021523185A (ja) | 2018-05-15 | 2021-09-02 | イミュノミック セラピューティックス， インコーポレイテッドＩｍｍｕｎｏｍｉｃ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | アレルゲンを含む改善されたｌａｍｐ構築物 |
| TWI852977B (zh) | 2019-01-10 | 2024-08-21 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
| KR20220083773A (ko) | 2019-10-18 | 2022-06-20 | 이뮤노믹 쎄라퓨틱스, 인크. | 암 항원을 포함하는 개선된 lamp 구축물 |
| EP4061405A1 (en) | 2019-11-18 | 2022-09-28 | Janssen Biotech, Inc. | Vaccines based on mutant calr and jak2 and their uses |
| EP4175664A2 (en) | 2020-07-06 | 2023-05-10 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| WO2022009049A1 (en) | 2020-07-06 | 2022-01-13 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| WO2022009051A1 (en) | 2020-07-06 | 2022-01-13 | Janssen Biotech, Inc. | A method for determining responsiveness to prostate cancer treatment |
| CA3247515A1 (en) | 2022-04-10 | 2023-10-19 | Immunomic Therapeutics, Inc. | Bicistronic lamp constructions comprising genes that enhance the immune response and methods of their use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2958076B2 (ja) * | 1990-08-27 | 1999-10-06 | 株式会社ビタミン研究所 | 遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法 |
| US5334761A (en) * | 1992-08-28 | 1994-08-02 | Life Technologies, Inc. | Cationic lipids |
| AU6044994A (en) * | 1993-02-19 | 1994-09-14 | Nippon Shinyaku Co. Ltd. | Glycerol derivative, device and pharmaceutical composition |
| DE19521412A1 (de) | 1995-06-14 | 1996-12-19 | Boehringer Mannheim Gmbh | Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung |
| GB9512363D0 (en) * | 1995-06-17 | 1995-08-16 | Bass Plc | Liquid containers and method of manufacture thereof |
| FR2759382A1 (fr) * | 1997-02-10 | 1998-08-14 | Transgene Sa | Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique |
-
1997
- 1997-12-12 FR FR9715805A patent/FR2759382A1/fr not_active Withdrawn
-
1998
- 1998-02-10 AT AT98908156T patent/ATE193886T1/de not_active IP Right Cessation
- 1998-02-10 DE DE69800178T patent/DE69800178T2/de not_active Expired - Fee Related
- 1998-02-10 WO PCT/FR1998/000250 patent/WO1998034910A1/fr not_active Ceased
- 1998-02-10 PT PT98908156T patent/PT901463E/pt unknown
- 1998-02-10 AU AU66266/98A patent/AU727204B2/en not_active Ceased
- 1998-02-10 CA CA002251999A patent/CA2251999A1/fr not_active Abandoned
- 1998-02-10 JP JP10533896A patent/JP2000510869A/ja not_active Ceased
- 1998-02-10 ES ES98908156T patent/ES2149043T3/es not_active Expired - Lifetime
- 1998-02-10 DK DK98908156T patent/DK0901463T3/da active
- 1998-02-10 EP EP98908156A patent/EP0901463B1/fr not_active Expired - Lifetime
- 1998-02-10 US US09/171,129 patent/US6218370B1/en not_active Expired - Fee Related
-
2000
- 2000-08-31 GR GR20000402004T patent/GR3034317T3/el not_active IP Right Cessation
-
2001
- 2001-03-02 US US09/796,650 patent/US6743781B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT901463E (pt) | 2000-12-29 |
| GR3034317T3 (en) | 2000-12-29 |
| US6218370B1 (en) | 2001-04-17 |
| AU6626698A (en) | 1998-08-26 |
| DE69800178D1 (de) | 2000-07-20 |
| EP0901463A1 (fr) | 1999-03-17 |
| FR2759382A1 (fr) | 1998-08-14 |
| EP0901463B1 (fr) | 2000-06-14 |
| JP2000510869A (ja) | 2000-08-22 |
| ATE193886T1 (de) | 2000-06-15 |
| DE69800178T2 (de) | 2001-02-15 |
| US6743781B2 (en) | 2004-06-01 |
| US20010036927A1 (en) | 2001-11-01 |
| ES2149043T3 (es) | 2000-10-16 |
| WO1998034910A1 (fr) | 1998-08-13 |
| AU727204B2 (en) | 2000-12-07 |
| CA2251999A1 (fr) | 1998-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3034317T3 (en) | Glycerolipidic compounds used for the transfer of an active substance into a target cell | |
| IS7170A (is) | Bensóþíasepín og bensóþíadíasepínafleiður með tálmavirkni gegn dausgarnargallsýruflutningi (ileal bile acid transport, IBAT) til að meðhöndla fitudreyra | |
| SE0000772D0 (sv) | Chemical compounds | |
| HU9502811D0 (en) | N-acyl-sulfamic acid esters (or thioesters), n-acyl-sulfonamides and n-sulfonyl-carbamic-acid-esters (or thioesters) as hypercholesterolemic agents | |
| DK0820481T3 (da) | Nye organiske siliconeforbindelser med en funktionel carboxylgruppe samt fremgangsmåde til fremstilling deraf | |
| FR2765478B1 (fr) | Nouvelles compositions cosmetiques comprenant un polymere filmogene | |
| NZ290757A (en) | Delivery of nucleic acid into a cell | |
| ES2147376T3 (es) | Composicion de electrolito polimero basada en la quimica de los tiol-enos. | |
| ES2177058T3 (es) | Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p. | |
| AU3094389A (en) | Substrates for phospholipases | |
| DK359387D0 (da) | Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling | |
| DE59805997D1 (de) | Phospholipidanaloge verbindungen | |
| ES467697A1 (es) | Procedimiento para la obtencion de protectores contra la in-flamacion a base de derivados del acido fosfonocarboxilico | |
| AU580868B2 (en) | Sylil-containing nail enamel | |
| DK0816368T3 (da) | Kemisk phosphorylering af oligonukleotider og reaktanter anvendt dertil | |
| ES467496A1 (es) | Procedimiento para preparar derivados de imidazol. | |
| TR200002273T2 (tr) | Hepatit B virüsü (HBV) retroviral ters transkriptaz ve DNA polimeraz inhibe edicilerini içeren antiviraller gibi nükleozidlerin analogları. | |
| TR200100740T2 (tr) | Tiyazolilsinnamonitriller ve haşere kontrol edici ajanlar | |
| MX170732B (es) | Composicion de derivados de succinimida y su uso | |
| ES8603809A1 (es) | Un procedimiento para preparar un derivado de fluoralilamina | |
| DE69823742D1 (de) | Etheraminalkoxylate enthaltende Brennstoffzusammensetzungen | |
| ES8506113A1 (es) | Un metodo de electrodepositar una superficie electroconductora que sirve como electrodo | |
| BR9813923A (pt) | N n - bis(sulfonil) hidrazinas úteis como agentes antineoplásicos | |
| EA200001107A1 (ru) | ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ | |
| ATE61341T1 (de) | N-substituierte, estergruppen enthaltende acrylamide. |